NSPMP COVID 19 Bulletin – October 2020 (PDF Download, 215KB)
Health Canada Exemption – October 1, 2020 (PDF Download, 154KB)
NSPMP COVID 19 Bulletin – March 2020 (PDF Download, 376KB)
Health Canada Exemption – March 19, 2020 (PDF Download, 437KB)
October 2020 Bulletin
Important Information for Prescribers and Pharmacists:
- Health Canada's CDSA Exemptions
May 2020 Bulletin
Important Information for Pharmacists and Pharmacy Teams:
- The Nova Scotia generic HCN should not be used
NSPMP Announcement: Benzodiazepine Integration
As part of the 2017-2020 Strategic Plan, the NSPMP will begin to integrate benzodiazepine data as part of our monitoring activities on Saturday, October 20th (12:01am).
Important information for prescribers and pharmacies:
- Benzodiazepine prescribers who are not currently registered with NSPMP will need to complete a registration form to obtain an NSPMP ID by October 20th to avoid having their prescriptions held at the pharmacy.
- Benzodiazepines prescriptions will continue to be written on regular prescription pads (duplicate pads are not required)
- Benzodiazepine prescribing histories will be available via NSPMP’s e-Access portal on October 20th
For more information, please review our October 4th 2018 Media Release and the benzodiazepine information outlined in our Frequently Asked Questions document.
*NEW*: Re-Order Duplicate Prescription Pads Online
Prescribers who are currently registered with the NSPMP can now re-order duplicate pads via email (PMP@medavie.bluecross.ca) or fax: 902-481-3157. Once received, your order will be delivered via courier within three business days.
CLICK HERE to submit your order via email.
*Effective October 10, 2019, the duplicate pads will be manufactured differently.
(
E-Prescribing is available through the DIS Portal
NSPMP allows for e-Prescribing of monitored drugs though the DIS.
More information on e-Prescribing is available here
